Founded in 2003, Bionime is a global innovator in Blood Glucose Management, specializing in the research, design, manufacturing, and marketing of advanced solutions for personal, Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and professional use, Point-of-Care Testing (POCT). Bionime, to better connect with local markets, has established subsidiaries across four continents and is actively cultivating a network of distributors from nearly 100 countries worldwide, working together to manage the global market.